Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services — Pittsburgh, Pennsylvania

Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services has participated in 1 clinical trials.

Therapeutic areas: Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia.

Sponsors: Tigris Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services?

Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services conducted?

Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services has 1 clinical trials on record. Their work covers Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia.

Is Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services accredited by Crixeo Clinical Trials?

Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Magee-Womens Hospital, Dept of OB/GYN & Reproductive Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.